Tamoxifen citrate import duties
Executive Summary
Suspension would continue through Jan. 1, 1996, under legislation (S 446) Sen. Roth (D-Del.) introduces Feb. 26. The chemical is the active ingredient in the breast cancer therapy Nolvadex, which is manufacutured in Delaware by Zeneca Pharmaceuticals, formerly ICI Pharmaceuticals (see related story, p. 22).